| Basal ganglia dysfunction in idiopathic REM sleep behaviour disorder parallels that in early Parkinson’s disease M Rolinski, L Griffanti, P Piccini, AA Roussakis, K Szewczyk-Krolikowski, ... Brain 139 (8), 2224-2234, 2016 | 141 | 2016 |
| Serotonin-to-dopamine transporter ratios in Parkinson disease: Relevance for dyskinesias AA Roussakis, M Politis, D Towey, P Piccini Neurology 86 (12), 1152-1158, 2016 | 81 | 2016 |
| Motor associations of iron accumulation in deep grey matter nuclei in Parkinson's disease: A cross‐sectional study of iron‐related magnetic resonance imaging susceptibility A Martin‐Bastida, NP Lao‐Kaim, C Loane, M Politis, AA Roussakis, ... European journal of neurology 24 (2), 357-365, 2017 | 65 | 2017 |
| Relationship between neuromelanin and dopamine terminals within the Parkinson’s nigrostriatal system A Martín-Bastida, NP Lao-Kaim, AA Roussakis, GE Searle, Y Xing, ... Brain 142 (7), 2023-2036, 2019 | 58 | 2019 |
| 11C‐PE2I and 18F‐Dopa PET for assessing progression rate in Parkinson's: A longitudinal study W Li, NP Lao‐Kaim, AA Roussakis, A Martín‐Bastida, N Valle‐Guzman, ... Movement Disorders 33 (1), 117-127, 2018 | 53 | 2018 |
| PET imaging in Huntington’s disease AA Roussakis, P Piccini Journal of Huntington's Disease 4 (4), 287-296, 2015 | 26 | 2015 |
| Longitudinal functional connectivity changes related to dopaminergic decline in Parkinson’s disease W Li, NP Lao-Kaim, AA Roussakis, A Martín-Bastida, N Valle-Guzman, ... NeuroImage: Clinical 28, 102409, 2020 | 20 | 2020 |
| Molecular imaging of neuroinflammation in idiopathic Parkinson's disease AA Roussakis, P Piccini International review of neurobiology 141, 347-363, 2018 | 19 | 2018 |
| Multimodal dopamine transporter (DAT) imaging and magnetic resonance imaging (MRI) to characterise early Parkinson's disease E Porter, AA Roussakis, NP Lao-Kaim, P Piccini Parkinsonism & Related Disorders 79, 26-33, 2020 | 15 | 2020 |
| Clinical utility of DaTscan™(123I-Ioflupane Injection) in the diagnosis of Parkinsonian Syndromes AA Roussakis, P Piccini, M Politis Degenerative Neurological and Neuromuscular Disease, 33-39, 2013 | 15 | 2013 |
| Astrocytes in Parkinson's disease: from preclinical assays to in vivo imaging and therapeutic probes Z Zeng, AA Roussakis, NP Lao-Kaim, P Piccini Neurobiology of Aging 95, 264-270, 2020 | 13 | 2020 |
| Brain imaging and impulse control disorders in Parkinson’s disease AA Roussakis, NP Lao–Kaim, P Piccini Current Neurology and Neuroscience Reports 19, 1-7, 2019 | 9 | 2019 |
| Distinct dopaminergic abnormalities in traumatic brain injury and Parkinson’s disease PO Jenkins, AA Roussakis, S De Simoni, N Bourke, J Fleminger, J Cole, ... Journal of Neurology, Neurosurgery & Psychiatry 91 (6), 631-637, 2020 | 8 | 2020 |
| Astrogliosis in aging and Parkinson’s disease dementia: a new clinical study with 11C-BU99008 PET MA Mohamed, Z Zeng, M Gennaro, NP Lao-Kaim, JFM Myers, ... Brain Communications 4 (5), fcac199, 2022 | 7 | 2022 |
| Positioning imatinib for pulmonary arterial hypertension: A phase I/II design comprising dose finding and single-arm efficacy MR Wilkins, MA Mckie, M Law, AA Roussakis, L Harbaum, C Church, ... Pulmonary Circulation 11 (4), 20458940211052823, 2021 | 6 | 2021 |
| A PET-CT study on neuroinflammation in Huntington’s disease patients participating in a randomized trial with laquinimod AA Roussakis, M Gennaro, MF Gordon, R Reilmann, B Borowsky, ... Brain Communications 5 (2), fcad084, 2023 | 5 | 2023 |
| Parkinson’s disease laterality: a 11C-PE2I PET imaging study AA Roussakis, Z Zeng, NP Lao-Kaim, A Martin-Bastida, P Piccini Journal of Neurology 268, 582-589, 2021 | 5 | 2021 |
| Dopamine transporter density in de novo Parkinson’s disease does not relate to the development of levodopa-induced dyskinesias AA Roussakis, M Gennaro, NP Lao-Kaim, D Towey, P Piccini Journal of neuroinflammation and neurodegenerative diseases 3 (1), 2019 | 5 | 2019 |
| Dissociable effects of age and Parkinson’s disease on instruction-based learning BL Parkin, RE Daws, I Das-Neves, IR Violante, E Soreq, AA Faisal, ... Brain communications 3 (3), fcab175, 2021 | 3 | 2021 |
| Parkinson’s disease progression is associated with increased putaminal serotonin to dopamine transporter ratio: relevance for dyskinesias (I3-1B) A Roussakis, M Politis, D Towey, P Piccini Neurology 84 (14_supplement), I3-1B, 2015 | 3 | 2015 |
